Lisa M. Giles
CIK 1568850 · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$45.8K
Companies
4
Total Filings
29
Lifetime Open-Market Net
$50.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIST | Director | — | $1.27 | — | $0 | 6 | 2025-06-12 |
| HCWB | Director | 35,815 | $1.28 | $45.8K | $0 | 5 | 2024-06-17 |
| GenMark Diagnostics, Inc. (GNMK) Delisted | Director | 0 | $24.04 | $0 | $35.8K | 14 | 2021-04-22 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | 1,500 | — | — | $15.1K | 3 | 2014-01-23 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-22 | GenMark Diagnostics, Inc. (GNMK) Delisted | Mixed | −87,072 | -$2.09M | EDGAR |
| 2021-02-19 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +7,782 | $0 | EDGAR |
| 2020-10-05 | MIST | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +13,825 | $0 | EDGAR |
| 2019-11-01 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +528 | $0 | EDGAR |
| 2019-08-02 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +702 | $0 | EDGAR |
| 2019-06-04 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +17,937 | $0 | EDGAR |
| 2018-05-29 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +17,107 | $0 | EDGAR |
| 2017-05-30 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +6,981 | $0 | EDGAR |
| 2016-08-22 | GenMark Diagnostics, Inc. (GNMK) Delisted | Buy (P) | +177 | $1.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.